Pharma Has High Hopes Of Pilot On Simultaneous Advice From EU Countries
Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.